Javier Garcia-Perez
Overview
Explore the profile of Javier Garcia-Perez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pachon Olmos V, Pollan M, Fernandez de Larrea-Baz N, Fernandez-Morata J, Ruiz-Moreno E, Garcia-Perez J, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002301
Background/objectives: The 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations benefit primary prevention and survivor outcomes. This study evaluated the adherence to these recommendations during...
2.
Contreras-Llanes M, Alguacil J, Capelo R, Gomez-Ariza J, Garcia-Perez J, Perez-Gomez B, et al.
J Xenobiot
. 2025 Feb;
15(1).
PMID: 39997372
Huelva is a city in SW Spain with 150,000 inhabitants, located in the proximity of two heavy chemical industry complexes, the highest naturally occurring radioactive material (NORM) waste (phosphogypsum) stacks...
3.
Jimenez T, Dominguez-Castillo A, Fernandez de Larrea-Baz N, Lucas P, Sierra M, Maeso S, et al.
Environ Health Prev Med
. 2024 Nov;
29:65.
PMID: 39581598
Background: Mammographic density (MD) is a well-established risk factor for breast cancer. Air pollution is a major public health concern and a recognized carcinogen. We aim to investigate the association...
4.
Robles G, Dellucci T, Garcia-Perez J, Starks T
J Mens Stud
. 2024 Oct;
32(3):421-449.
PMID: 39372964
The literature differentiates between two domains of machismo: traditional machismo and caballerismo. Research has largely focused on measuring machismo among English speakers. We evaluated whether Estrada's (2011) 2-factor model of...
5.
Garcia-Perez J, Borobia A, Perez-Olmeda M, Portoles A, Castano L, Campins-Arti M, et al.
iScience
. 2024 Sep;
27(9):110728.
PMID: 39286494
CombiVacS study has demonstrated a strong immune response of the heterologous ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to assess the humoral immune response against SARS-CoV-2, 28 ...
6.
Munoz-Callejas A, Sanchez-Abad I, Ramos-Manzano A, San Antonio E, Gonzalez-Sanchez E, Silvan J, et al.
Transl Res
. 2024 Aug;
274:10-20.
PMID: 39182668
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by severe organ damage and lacking curative treatment. While various immune cell types, especially dysfunctional B and T cells and...
7.
San Antonio E, Silvan J, Sevilla-Montero J, Gonzalez-Sanchez E, Munoz-Callejas A, Sanchez-Abad I, et al.
Front Immunol
. 2024 Aug;
15:1403104.
PMID: 39100683
Background: Early diagnosis and treatment of Systemic lupus erythematosus (SLE) and Systemic sclerosis (SSc) present significant challenges for clinicians. Although various studies have observed changes in serum levels of selectins...
8.
Garcia-Perez J, Fernandez de Larrea-Baz N, Lope V, Dominguez-Castillo A, Espinosa A, Dierssen-Sotos T, et al.
Sci Total Environ
. 2024 Jun;
946:174347.
PMID: 38944307
Background: Prostate cancer (PC) is the second most frequent tumor in men worldwide; however, its etiology remains largely unknown, with the exception of age and family history. The wide variability...
9.
Jimenez T, Dominguez-Castillo A, Fernandez de Larrea-Baz N, Lucas P, Sierra M, Salas-Trejo D, et al.
Sci Total Environ
. 2024 Apr;
928:172463.
PMID: 38615764
Background: Mammographic density (MD) is the most important breast cancer biomarker. Ambient pollution is a carcinogen, and its relationship with MD is unclear. This study aims to explore the association...
10.
Rodriguez-Mora S, Corona M, Solera Sainero M, Mateos E, Torres M, Sanchez-Menendez C, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894433
Individuals with chronic myeloid leukemia (CML) constitute a unique group within individuals with oncohematological disease (OHD). They receive treatment with tyrosine kinase inhibitors (TKIs) that present immunomodulatory properties, and they...